Home›Stock Screener›Influx Healthtech›Financial Statements

Influx Healthtech Complete Financial Statements

6 Years of Data
2026 - 2021

In FYNone, Influx Healthtech (INFLUX) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 13.6% and ROE of 19.8%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse INFLUX shareholding pattern to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 13.61% 2026 data
EBITDA Margin 20.41% 2026 data
Operating Margin 20.00% 2026 data
Return on Assets 16.13% 2026 data
Return on Equity 19.80% 2026 data

Balance Sheet Ratios

Equity Ratio 81.45% 2026 data
Asset Turnover 1.19 2026 data

INFLUX Revenue, Net Profit & EBITDA — Year-on-Year Growth

INFLUX YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Also explore INFLUX share price data to track price trends across different timeframes.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+77.1%
Year-over-Year
Equity Growth
+180.6%
Year-over-Year
Operating Cash Flow Growth
-22.2%
Year-over-Year
Investing Cash Flow Growth
-12.5%
Year-over-Year
Financing Cash Flow Growth
+100.0%
Year-over-Year

INFLUX Income Statement — Revenue, EBITDA & Net Profit

Influx Healthtech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 13.6%. For live price, earnings ratios and company overview, see INFLUX screener.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 0 147 105 100 76 59 0
Expenses 0 117 84 83 65 53 0
EBITDA 0 30 21 17 11 6 0
Operating Profit Margin % 0.00% 20.00% 20.00% 17.00% 14.00% 11.00% 0.00%
Depreciation 0 4 3 2 1 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 0 27 18 15 10 6 0
Tax 0 7 5 4 3 2 0
Net Profit 0 20 13 11 7 5 0
Earnings Per Share (₹) 0.00 9.35 7.36 6.13 3.96 1801.90 -1.75

INFLUX Balance Sheet — Assets, Liabilities & Shareholders' Equity

INFLUX total assets ₹124 Cr, total equity ₹101 Cr, total liabilities ₹ Cr (2026) — ROE 19.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021
ASSETS
Total Assets 124 70 41 28 18 0
Current Assets 81 49 26 20 14 0
Fixed Assets 31 19 14 6 3 0
Capital Work in Progress 4 0 0 0 0 0
Investments 16 0 0 0 0 0
Other Assets 0 52 27 22 15 0
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 101 36 23 12 5 0
Share Capital 23 18 0 0 0 0
Reserves & Surplus 78 18 23 12 5 0

INFLUX Cash Flow Statement — Operating, Investing & Financing

Influx Healthtech operating cash flow ₹7 Cr, investing ₹-9 Cr, financing ₹0 Cr, net cash flow ₹-2 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities 7 9 7 4 0
Investing Activities -9 -8 -5 -3 0
Financing Activities 0 -1 0 1 0
Net Cash Flow -2 0 2 1 0